FX.co ★ Teva Pharmaceutical Shares Fall 13% Following Lower-than-Expected Q4 Results

Teva Pharmaceutical Industries Ltd. (TEVA) experienced a significant drop in stock value, falling by 13.92% during Wednesday afternoon trading after announcing its fourth-quarter earnings. The company revealed adjusted earnings of $0.71 per share alongside sales totaling $4.23 billion for the quarter, contributing to the decline in its stock price.

Presently, TEVA shares are valued at $18.51, marking a decrease of $3.02 from a previous closing price of $21.53. The stock began the day at $18.61 and has fluctuated within a range of $18.50 to $19.74 throughout the session.

For the past year, TEVA's share prices have ranged from a low of $11.62 to a high of $22.80. Today's trading volume has reached approximately 25.82 million shares, significantly exceeding the average daily volume of around 9.81 million shares.